Exenatide (Byetta, Bydureon) Explained: The First GLP-1 and Why It Came From a Lizard

If you have heard that Ozempic owes its existence to a lizard, the honest answer is yes — but the full story runs through a Bronx veterans' hospital, three decades of skepticism, and a regulatory landscape that looked very different before anyone had heard of semaglutide. Exenatide was the first GLP-1 receptor agonist to reach

Exenatide (Byetta, Bydureon) Explained: The First GLP-1 and Why It Came From a Lizard Read More »

Dulaglutide (Trulicity) Explained: A Weekly GLP-1 With a Cardiovascular Outcomes Story

If you are reading about Trulicity because someone in your life takes it for weight loss, the first thing worth knowing is that dulaglutide does not have an FDA-approved weight-management indication. It never has. The confusion is understandable — Trulicity belongs to the same GLP-1 receptor agonist drug class as Ozempic and Wegovy, and the

Dulaglutide (Trulicity) Explained: A Weekly GLP-1 With a Cardiovascular Outcomes Story Read More »

Lion’s Mane for Focus: What the Mori 2009 RCT Showed and What It Didn’t

If you're searching for whether lion's mane mushroom improves focus, the honest answer is: it may support cognitive function in older adults with mild cognitive decline, but the evidence for healthy adults trying to sharpen a workday is nearly absent. The single most-cited human RCT tested lion's mane in Japanese adults aged 50-80 with mild

Lion’s Mane for Focus: What the Mori 2009 RCT Showed and What It Didn’t Read More »

Liraglutide (Saxenda, Victoza) Explained: The Daily GLP-1 That Started the Class

If you have heard about Ozempic or Wegovy in the past few years, you may not realize those drugs belong to a class that has been in clinical use since 2010, built on a molecule called liraglutide. The natural question is whether the original version is still relevant now that once-weekly alternatives dominate the headlines.

Liraglutide (Saxenda, Victoza) Explained: The Daily GLP-1 That Started the Class Read More »

Scroll to Top